Avidity biosciences to participate in upcoming investor conference

San diego , april 1, 2025 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that avidity management will participate in a fireside chat during the following investor conference: 24th annual needham virtual healthcare conference on tuesday, april 8, 2025, at 3:00 p.m. et live webcast of the event, up-to-date event details and an archived replay will be available on the "events and presentations" page in the "investors" section of avidity's website at https://aviditybiosciences.investorroom.com/events-and-presentations.
RNA Ratings Summary
RNA Quant Ranking